Dexcom Inc Stock Technical Analysis
| DXCM Stock | USD 73.34 0.48 0.66% |
As of the 27th of January, DexCom shows the Downside Deviation of 3.55, mean deviation of 1.68, and Coefficient Of Variation of 2373.03. DexCom Inc technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm DexCom Inc jensen alpha, potential upside, as well as the relationship between the Potential Upside and skewness to decide if DexCom Inc is priced favorably, providing market reflects its regular price of 73.34 per share. Given that DexCom has jensen alpha of 0.0584, we urge you to verify DexCom Inc's prevailing market performance to make sure the company can sustain itself at a future point.
DexCom Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as DexCom, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to DexComDexCom's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.DexCom Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 85.19 | Strong Buy | 26 | Odds |
Most DexCom analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand DexCom stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of DexCom Inc, talking to its executives and customers, or listening to DexCom conference calls.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.099 | Earnings Share 1.8 | Revenue Per Share | Quarterly Revenue Growth 0.216 | Return On Assets |
The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
DexCom 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to DexCom's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of DexCom.
| 10/29/2025 |
| 01/27/2026 |
If you would invest 0.00 in DexCom on October 29, 2025 and sell it all today you would earn a total of 0.00 from holding DexCom Inc or generate 0.0% return on investment in DexCom over 90 days. DexCom is related to or competes with STERIS Plc, Insulet, Zimmer Biomet, Koninklijke Philips, Smith Nephew, Laboratory, and Waters. DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose ... More
DexCom Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure DexCom's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess DexCom Inc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.55 | |||
| Information Ratio | 0.012 | |||
| Maximum Drawdown | 16.0 | |||
| Value At Risk | (2.87) | |||
| Potential Upside | 3.31 |
DexCom Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for DexCom's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as DexCom's standard deviation. In reality, there are many statistical measures that can use DexCom historical prices to predict the future DexCom's volatility.| Risk Adjusted Performance | 0.0382 | |||
| Jensen Alpha | 0.0584 | |||
| Total Risk Alpha | (0.16) | |||
| Sortino Ratio | 0.0091 | |||
| Treynor Ratio | 0.1631 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of DexCom's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
DexCom January 27, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0382 | |||
| Market Risk Adjusted Performance | 0.1731 | |||
| Mean Deviation | 1.68 | |||
| Semi Deviation | 3.33 | |||
| Downside Deviation | 3.55 | |||
| Coefficient Of Variation | 2373.03 | |||
| Standard Deviation | 2.69 | |||
| Variance | 7.24 | |||
| Information Ratio | 0.012 | |||
| Jensen Alpha | 0.0584 | |||
| Total Risk Alpha | (0.16) | |||
| Sortino Ratio | 0.0091 | |||
| Treynor Ratio | 0.1631 | |||
| Maximum Drawdown | 16.0 | |||
| Value At Risk | (2.87) | |||
| Potential Upside | 3.31 | |||
| Downside Variance | 12.64 | |||
| Semi Variance | 11.12 | |||
| Expected Short fall | (1.50) | |||
| Skewness | (2.39) | |||
| Kurtosis | 13.33 |
DexCom Inc Backtested Returns
As of now, DexCom Stock is very steady. DexCom Inc secures Sharpe Ratio (or Efficiency) of 0.058, which denotes the company had a 0.058 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for DexCom Inc, which you can use to evaluate the volatility of the firm. Please confirm DexCom's Downside Deviation of 3.55, coefficient of variation of 2373.03, and Mean Deviation of 1.68 to check if the risk estimate we provide is consistent with the expected return of 0.16%. DexCom has a performance score of 4 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.63, which means possible diversification benefits within a given portfolio. As returns on the market increase, DexCom's returns are expected to increase less than the market. However, during the bear market, the loss of holding DexCom is expected to be smaller as well. DexCom Inc right now shows a risk of 2.79%. Please confirm DexCom Inc skewness, and the relationship between the potential upside and rate of daily change , to decide if DexCom Inc will be following its price patterns.
Auto-correlation | 0.44 |
Average predictability
DexCom Inc has average predictability. Overlapping area represents the amount of predictability between DexCom time series from 29th of October 2025 to 13th of December 2025 and 13th of December 2025 to 27th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of DexCom Inc price movement. The serial correlation of 0.44 indicates that just about 44.0% of current DexCom price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.44 | |
| Spearman Rank Test | 0.34 | |
| Residual Average | 0.0 | |
| Price Variance | 5.63 |
DexCom technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
DexCom Inc Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of DexCom Inc volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About DexCom Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of DexCom Inc on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of DexCom Inc based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on DexCom Inc price pattern first instead of the macroeconomic environment surrounding DexCom Inc. By analyzing DexCom's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of DexCom's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to DexCom specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 4.82 | 4.62 | 5.31 | 9.61 | Days Of Inventory On Hand | 153.18 | 124.18 | 111.77 | 68.37 |
DexCom January 27, 2026 Technical Indicators
Most technical analysis of DexCom help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for DexCom from various momentum indicators to cycle indicators. When you analyze DexCom charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0382 | |||
| Market Risk Adjusted Performance | 0.1731 | |||
| Mean Deviation | 1.68 | |||
| Semi Deviation | 3.33 | |||
| Downside Deviation | 3.55 | |||
| Coefficient Of Variation | 2373.03 | |||
| Standard Deviation | 2.69 | |||
| Variance | 7.24 | |||
| Information Ratio | 0.012 | |||
| Jensen Alpha | 0.0584 | |||
| Total Risk Alpha | (0.16) | |||
| Sortino Ratio | 0.0091 | |||
| Treynor Ratio | 0.1631 | |||
| Maximum Drawdown | 16.0 | |||
| Value At Risk | (2.87) | |||
| Potential Upside | 3.31 | |||
| Downside Variance | 12.64 | |||
| Semi Variance | 11.12 | |||
| Expected Short fall | (1.50) | |||
| Skewness | (2.39) | |||
| Kurtosis | 13.33 |
DexCom January 27, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as DexCom stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 99,300 | ||
| Daily Balance Of Power | 0.35 | ||
| Rate Of Daily Change | 1.01 | ||
| Day Median Price | 73.33 | ||
| Day Typical Price | 73.33 | ||
| Price Action Indicator | 0.25 |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.099 | Earnings Share 1.8 | Revenue Per Share | Quarterly Revenue Growth 0.216 | Return On Assets |
The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.